Steve Wilcox focuses his practice on mergers and acquisitions, corporate financing transactions (including public offerings and venture capital investments) and licensing and collaborations. Most of his clients are engaged in the biotech, medical device and pharmaceutical industries. In addition to transactional work, he regularly counsels companies on a range of federal securities and corporate governance matters.

Steve is a founder and former chair of the firm’s life sciences practice group.